MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/ccm.0b013e31821e8791

Медицинская библиотека · Critical care medicine · 2011

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.

Jensen Jens U, Hein Lars, Lundgren Bettina, Bestle Morten H, Mohr Thomas T, Andersen Mads H, Thornberg Klaus J, Løken Jesper, Steensen Morten, Fox Zoe, Tousi Hamid, Søe-Jensen Peter, Lauritsen Anne Ø, Strange Ditte, Petersen Pernille L, Reiter Nanna, Hestad Søren, Thormar Katrin, Fjeldborg Paul, Larsen Kim M, Drenck Niels E, Ostergaard Christian, Kjær Jesper, Grarup Jesper, Lundgren Jens D, Procalcitonin And Survival Study (PASS) Group

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

For patients in intensive care units, sepsis is a common and potentially deadly complication and prompt initiation of appropriate antimicrobial therapy improves prognosis. The objective of this trial was to determine whether a strategy of antimicrobial spectrum escalation, guided by daily measurements of the biomarker procalcitonin, could reduce the time to appropriate therapy, thus improving survival.

DESIGN

Randomized controlled open-label trial.

SETTING

Nine multidisciplinary intensive care units across Denmark.

PATIENTS: A total of 1,200 critically ill patients were included after meeting the following eligibility requirements: expected intensive care unit stay of ≥ 24 hrs, nonpregnant, judged to not be harmed by blood sampling, bilirubin <40 mg/dL, and triglycerides <1000 mg/dL (not suspensive).

INTERVENTIONS: : Patients were randomized either to the "standard-of-care-only arm," receiving treatment according to the current international guidelines and blinded to procalcitonin levels, or to the "procalcitonin arm," in which current guidelines were supplemented with a drug-escalation algorithm and intensified diagnostics based on daily procalcitonin measurements.

MEASUREMENTS AND MAIN

RESULTS

The primary end point was death from any cause at day 28; this occurred for 31.5% (190 of 604) patients in the procalcitonin arm and for 32.0% (191 of 596) patients in the standard-of-care-only arm (absolute risk reduction, 0.6%; 95% confidence interval [CI] -4.7% to 5.9%). Length of stay in the intensive care unit was increased by one day (p = .004) in the procalcitonin arm, the rate of mechanical ventilation per day in the intensive care unit increased 4.9% (95% CI, 3.0-6.7%), and the relative risk of days with estimated glomerular filtration rate <60 mL/min/1.73 m was 1.21 (95% CI, 1.15-1.27).

CONCLUSIONS

Procalcitonin-guided antimicrobial escalation in the intensive care unit did not improve survival and did lead to organ-related harm and prolonged admission to the intensive care unit. The procalcitonin strategy like the one used in this trial cannot be recommended.

Для цитирования: Jensen Jens U, Hein Lars, Lundgren Bettina, Bestle Morten H, Mohr Thomas T, Andersen Mads H, Thornberg Klaus J, Løken Jesper, Steensen Morten, Fox Zoe, Tousi Hamid, Søe-Jensen Peter, Lauritsen Anne Ø, Strange Ditte, Petersen Pernille L, Reiter Nanna, Hestad Søren, Thormar Katrin, Fjeldborg Paul, Larsen Kim M, Drenck Niels E, Ostergaard Christian, Kjær Jesper, Grarup Jesper, Lundgren Jens D, Procalcitonin And Survival Study (PASS) Group. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.. Critical care medicine. 2011. DOI: 10.1097/ccm.0b013e31821e8791.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.